NDA Submission

Related by string. NDA submission * NDAS . nda . Nda . NDAs : NDA convenor Sharad Yadav . NDA convener George . NDA convener . NDA Convener George . Alliance NDA . NDA convenor George / SUBMISSION . submissions . Submissions . SUBMISSIONS . submission : Letters submission form . submission triangle choke . submission guillotine choke . BLA submission . MAA submission * EvaMist NDA submission *

Related by context. Frequent words. (Click for all words.) 83 Patient Enrollment 81 Phase III Clinical Trial 81 FDA Accepts 81 Single Dose 80 Phase III Trial 80 Pivotal Phase III 80 Drug Candidate 79 Generic Version 78 Clinical Trial Results 77 Completes Enrollment 77 Pivotal Trial 76 Pivotal Study 76 Presents Positive 76 Pivotal Phase 75 Well Tolerated 75 FDA Clears 75 Positive Opinion 75 Preclinical Data 75 Pulmonary Arterial Hypertension 74 FDA Clearance 74 Extended Release 74 Initiate Phase 74 Smallpox Vaccine 74 Metastatic Melanoma 74 Cholesterol Drug 73 Recombinant Human 73 Prostate Cancer Patients 72 II Clinical Trial 72 Pediatric Patients 72 Receives FDA Clearance 72 Low Dose 72 Monotherapy 72 Announces FDA Clearance 72 Patients Treated 71 Overactive Bladder 71 Elderly Patients 71 Antipsychotic 71 Cervical Cancer Vaccine 71 Blood Thinner 71 Significantly Reduces 71 Heart Failure Patients 71 Diabetic Patients 71 Tumor Growth 71 Study Demonstrates 70 Advanced Prostate Cancer 70 Metastatic Colorectal Cancer 70 Golimumab 70 Transcept Pharmaceuticals 70 RNAi Therapeutics 70 Coadministration 70 Combination Therapy 70 FDA Approves 70 Allergic Rhinitis 70 Pirfenidone 70 Diabetic Macular Edema 70 Patients Undergoing 70 Announces Initiation 70 FY# Guidance 70 Reduces Risk 70 Develop Novel 70 Kuvan R 70 Benign Prostatic Hyperplasia 70 Dasatinib 70 Initiates Phase 69 Chronic Hepatitis C 69 FDA Approval 69 Aliskiren 69 Panzem R 69 Patent Covering 69 Oral Solution 69 Patient Outcomes 69 Lung Cancer Patients 69 Ofatumumab 69 Venous Thromboembolism 69 Drug Resistant 69 refractory chronic lymphocytic 68 Small Molecule 68 Bevacizumab 68 Eltrombopag 68 Microplasmin 68 Ambrisentan 68 Gastric Cancer 68 Etanercept 68 Atopic Dermatitis 68 FDA Orphan Drug 68 Postmenopausal Women 68 Chronic Hepatitis B 68 Breast Cancer Treatment 68 Epratuzumab 68 Provides Guidance 68 Cethromycin 68 Monoclonal Antibody 68 BioDelivery Sciences 68 Inc Therapeutic Competitors 68 Vertex Pharmaceuticals Announces 68 Complete Response 68 Extended Release Tablets 68 Bortezomib 68 Anti Inflammatory 68 Receives Positive 67 Prostate Cancer Treatment

Back to home page